<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JOCR</journal-id><journal-title-group><journal-title>Journal of Organic Chemistry Research</journal-title></journal-title-group><issn pub-type="epub">2330-5231</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/JOCR.2018.62006</article-id><article-id pub-id-type="publisher-id">JOCR-25198</article-id><article-categories><subj-group subj-group-type="heading"><subject>JOCR20180200000_14212700.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>化学与材料</subject></subj-group></article-categories><title-group><article-title>
 
 
  [Bmim]BF4催化下三组分一锅法合成多取代吡喃并[2,3-c]吡唑类化合物
  Three Components One-Pot Synthesis of Multi-Pyrane[2,3-c]pyrazoles Catalyzed by [Bmim]BF4
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>梁</surname><given-names>杰</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>热孜亚·</surname><given-names>伊卜拉伊木</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>阿依古丽·</surname><given-names>巴拉提</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>null</addr-line></aff><aff id="aff1"><addr-line>新疆大学化学化工学院，石油天然气精细化工教育部&amp;amp;自治区重点实验室，新疆 乌鲁木齐</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>liangjie1023520@yeah.net(梁杰)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>04</month><year>2018</year></pub-date><volume>06</volume><issue>02</issue><fpage>39</fpage><lpage>44</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   本文报道了在离子液体[Bmim]BF<sub>4</sub>催化条件下，以吡唑酮，芳香醛和丙二腈为起始原料经三组分一锅法合成多取代吡喃并[2,3-c]吡唑类化合物。该方法具有操作简便、选择性好、原子利用率高和环境友好等优点，为此类化合物的研究提供了一种有效的合成方法。目标产物的结构均通过IR，1H-NMR和HR-MS进行表征。 This paper reports that on the catalytic condition of ionic liquid [Bmim]BF<sub>4</sub>, with pyrazolone, ar-omatic aldehyde and malononitrile as the starting materials, multi-pyrane[2,3-c]pyrazoles are synthesized by three-component one-pot reaction. This method has the advantages of simple op-eration, good selectivity, high atomic utilization rate and environmental friendliness, and provides an effective synthesis method for the study of these compounds. The structure of the products was characterized by IR, 1H-NMR and HR-MS. 
 
</p></abstract><kwd-group><kwd>离子液体，[Bmim]BF4，多组分反应，一锅法合成，吡喃并[2</kwd><kwd>3-c]吡唑类化合物, IONIC Liquids</kwd><kwd> [Bmim]BF4</kwd><kwd> Multicomponent Reactions</kwd><kwd> One-Pot Synthesis</kwd><kwd> Pyrano[2</kwd><kwd>3-c]pyrazoles</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>[Bmim]BF<sub>4</sub>催化下三组分一锅法合成 多取代吡喃并[2,3-c]吡唑类化合物<sup> </sup></title><p>梁杰<sup>*</sup>，热孜亚&#183;伊卜拉伊木，阿依古丽&#183;巴拉提</p><p>新疆大学化学化工学院，石油天然气精细化工教育部&amp;自治区重点实验室，新疆 乌鲁木齐</p><disp-formula id="hanspub.25198-formula62"><graphic xlink:href="//html.hanspub.org/file/3-2970106x5_hanspub.png"  xlink:type="simple"/></disp-formula><p>收稿日期：2018年5月6日；录用日期：2018年5月22日；发布日期：2018年5月30日</p><disp-formula id="hanspub.25198-formula63"><graphic xlink:href="//html.hanspub.org/file/3-2970106x6_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>本文报道了在离子液体[Bmim]BF<sub>4</sub>催化条件下，以吡唑酮，芳香醛和丙二腈为起始原料经三组分一锅法合成多取代吡喃并[2,3-c]吡唑类化合物。该方法具有操作简便、选择性好、原子利用率高和环境友好等优点，为此类化合物的研究提供了一种有效的合成方法。目标产物的结构均通过IR，<sup>1</sup>H-NMR和HR-MS进行表征。</p><p>关键词 :离子液体，[Bmim]BF<sub>4</sub>，多组分反应，一锅法合成，吡喃并[2,3-c]吡唑类化合物</p><disp-formula id="hanspub.25198-formula64"><graphic xlink:href="//html.hanspub.org/file/3-2970106x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2018 by authors and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/3-2970106x8_hanspub.png" /> <img src="//html.hanspub.org/file/3-2970106x9_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>多组分反应(MCRs)作为一种有效的合成方法在有机合成中具有广泛的应用价值，利用多组分反应可以合成一系列化学结构复杂，生理活性显著的有机化合物 [<xref ref-type="bibr" rid="hanspub.25198-ref1">1</xref>] 。此方法与传统意义的有机合成方法相比，其大多数多组分反应具有操作简便、高选择性、原子利用率高、减少分离纯化步骤、提高反应产率和环境友好等特点 [<xref ref-type="bibr" rid="hanspub.25198-ref2">2</xref>] [<xref ref-type="bibr" rid="hanspub.25198-ref3">3</xref>] 。因此，多组分反应合成方法现已成为有机合成领域中不可或缺的重要方法而受到越来越多科学家的关注。</p><p>离子液体具有非挥发性、热稳定高、低毒性及环境友好等诸多优点，在有机合成中具有广泛的应用。基于以上原因本文发展了一种高效的合成方法：在[Bmim]BF<sub>4</sub>催化条件下，以1-(4-羧基苯基)-3-异丙基吡唑-5-酮，芳香醛和和丙二腈为起始原料经三组分一锅法反应合成多取代吡喃并[2,3-c]吡唑类化合物。此类化合物具有各种潜在的生理活性，如抗炎 [<xref ref-type="bibr" rid="hanspub.25198-ref4">4</xref>] [<xref ref-type="bibr" rid="hanspub.25198-ref5">5</xref>] 、抗菌 [<xref ref-type="bibr" rid="hanspub.25198-ref6">6</xref>] [<xref ref-type="bibr" rid="hanspub.25198-ref7">7</xref>] 、酶抑制剂 [<xref ref-type="bibr" rid="hanspub.25198-ref8">8</xref>] ，在医药和农药领域具有广泛的应用价值。</p></sec><sec id="s4"><title>2. 实验部分</title><sec id="s4_1"><title>2.1. 仪器与试剂</title><p>产物的熔点用瑞士BUCHIB2540型熔点仪测定(温度计未校正)；质谱用API 2000质谱仪测定；核磁共振用VARIAN INOVA 400型核磁共振仪测定(CDC1<sub>3</sub>，DMSO-d<sub>6</sub>为溶剂，TMS为内标)；红外光谱BRUKER-EQUINOX5红外光谱仪测定(KBr压片)；元素分析用EA-1110元素分析仪测定。实验所用试剂均为分析纯，除特殊说明外未经处理直接使用。</p></sec><sec id="s4_2"><title>2.2. 离子液体的合成</title><p>离子液体[Bmim]BF<sub>4</sub>的合成原理图1所示：1-丁基-3-甲基咪唑四氟硼酸盐的合成路线分为2步，即中间体[Bmim]Br的合成和阴离子交换制备[Bmim]BF<sub>4</sub>。</p><p>1) 将12 ml N-甲基咪唑加入圆底烧瓶中，再加入19.2 ml溴代正丁烷在70℃搅拌48 h。冷却，用乙酸乙酯洗涤3次得到固体，抽滤，放入真空干燥箱干燥8 h，制得中间体[Bmim]Br。</p><p>2) 称取中间体0.2 mol加入250 ml圆底烧瓶，按摩尔比1:1.2加入氟硼酸钠及100 ml二氯甲烷，45℃下搅拌48 h。冷却，抽滤，减压蒸馏，真空干燥8 h得到目标产物1-丁基-3-甲基咪唑四氟硼酸盐[Bmim]BF<sub>4</sub>。</p></sec><sec id="s4_3"><title>2.3. 吡喃并[2,3-c]吡唑类化合物4a-4f的合成及结构表征</title><p>化合物4a-4f的反应如图2所示。将1.0 mol 1-(4-羧基苯基)-3-异丙基吡唑-5-酮，1.0 mol芳香醛和1.0 mol</p><p>图1. 离子液体[Bmim]BF<sub>4</sub>的合成</p><p>图2. 合成吡喃并[2,3-c]吡唑类化合物4a-4f</p><p>丙二腈溶于5 mL EtOH中，加入[Bmim]BF<sub>4</sub> (20 mol%)，混合均匀后在75℃反应2 h。通过薄层色谱(TLC)追踪直至反应完全结束，放置过夜析出晶体，减压蒸馏旋出溶剂，得到粗产品，然后用DMF/EtOH重结晶得到目标化合物4a-4f。</p><p>4a: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.97 (s, 1 H), 8.87 (s, 1 H), 8.04.(d, 2 H), 7.96 (d, 2 H), 4.60 (s, 1 H), 2.51 (s, 1H), 1.05 (d, 3H), 0.87 (d, 3H) ppm; IR (thin film): 3545, 3445, 3232, 3205, 2194, 1692, 1664, 1603, 1511, 1484, 1385, 1262, 1082, 861, 802, 755 cm<sup>−1</sup>; HRMS (TOF MS ES<sup>+</sup>) m/z [M + H]<sup>+</sup> calcd. for C<sub>24</sub>H<sub>22</sub>N<sub>4</sub>O<sub>5</sub> 447.1677, found 447.1673.</p><p>4b: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.97 (s, 1 H), 8.03 (d, 2 H), 7.97 (d, 2 H), 7.33 (d, 2 H), 7.22 (s, 2 H), 7.16 (d, 2 H), 4.77 (s, 1 H), 2.44 (s, 1 H), 1.04 (d, 3 H), 0.84 (d, 3 H) ppm; IR (thin film): 3433, 3445, 3325, 2184, 1719, 1661, 1607, 1526, 1395, 1236, 1091, 856, 815, 776 cm<sup>−1</sup>; HRMS (TOF MS ES<sup>+</sup>) m/z [M + H]<sup>+</sup> calcd. for C<sub>23</sub>H<sub>19</sub>FN<sub>4</sub>O<sub>3</sub> 419.1577, found 419.1573.</p><p>4c: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.98 (s, 1 H), 8.05 (d, 2 H), 7.98 (d, 2 H), 7.41 (d, 2 H), 7.32 (d, 2 H), 2.45 (s, 1 H), 1.04 (d, 3 H), 0.87 (d, 3 H) ppm; IR (thin film): 3447, 3344, 3177, 2185, 1715, 1644, 1614, 1536, 1384, 1265, 1118, 815, 788 cm<sup>−1</sup>; HRMS (TOF MS ES<sup>+</sup>) m/z [M + H]<sup>+</sup> calcd. for C<sub>23</sub>H<sub>19</sub>ClN<sub>4</sub>O<sub>3</sub> 435.1167, found 435.1165.</p><p>4d: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.99 (s, 1 H), 8.04 (d, 2 H), 7.98 (d, 2 H), 7.55 (d, 2 H), 7.26 (d, 2 H), 7.25 (s, 2 H) ppm; IR (thin film): 3474, 3294, 3175, 2188, 1707, 1655, 1607, 1527, 1484, 1394, 1205, 1086, 857, 804, 774 cm<sup>−1</sup>; HRMS (TOF MS ES<sup>+</sup>) m/z [M + H]<sup>+</sup> calcd. for C<sub>23</sub>H<sub>19</sub>BrN<sub>4</sub>O<sub>3</sub> 479.0679, found 479.0677.</p><p>4e: <sup>1</sup>H NMR (400 MHz, CDCl3): δ 12.96 (s, 1 H), 9.31 (s, 1 H), 8.04 (d, 2 H), 7.96 (d, 2 H), 7.15 (d, 2 H), 7.04 (d, 2 H), 6.70 (d, 2 H), 4.61 (s, 1 H), 2.51 (s, 1 H) 1.04 (d, 3 H), 0.85 (d, 3 H) ppm; IR (thin film): 3478, 3294, 3168, 2191, 1708, 1654, 1605, 1517, 1492, 1392, 1225, 1087, 857, 813, 792 cm<sup>−1</sup>; HRMS (TOF MS ES<sup>+</sup>) m/z [M + H]<sup>+</sup> calcd. for C<sub>23</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub> 417.1576, found 417.1574.</p><p>4f: 1H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.99 (s, 1 H), 9.31 (s, 1 H), 8.04 (d, 2 H), 7.98 (d, 2 H), 7.18 (s, 2 H), 7.13 (t, 1 H), 6.71 (d, 1 H), 6.65 (t, 2 H), 6.63 (t, 1 H), 2.51 (s, 1 H), 1.06 (d, 3 H), 0.89 (d, 3 H) ppm; IR (thin film): 3463, 3354, 3184, 2197, 1714, 1667, 1604, 1532, 1398, 1274, 1096, 814, 783 cm<sup>−1</sup>; HRMS (TOF MS ES<sup>+</sup>) m/z [M + H]<sup>+</sup> calcd. for C<sub>23</sub>H20N<sub>4</sub>O <sub>4 </sub>417.1577, found 417.1575.</p></sec></sec><sec id="s5"><title>3. 结果与讨论</title><sec id="s5_1"><title>3.1. 反应条件的筛选</title><p>以1-(4-羧基苯基)-3-异丙基吡唑-5-酮1 (1.0 mmol)，丙二腈2 (1.0 mmol)，4-甲氧基-3-羟基苯甲醛3a (1.0 mmol)为起始原料经一锅法三组分反应为模型，我们探讨了溶剂、催化剂类型、催化剂用量、反应时间以及反应温度对模型反应产率的影响(表1)。</p><p>首先筛选了不同的催化剂对模型反应的影响(表1，entries 1~3)。从表中可以看出，无催化剂条件下反应不能进行，离子液体[Bmim]BF<sub>4</sub>的催化活性要比HBF4高。其次，考察了EtOH、H<sub>2</sub>O、CH<sub>3</sub>CO<sub>2</sub>Et、CH<sub>2</sub>Cl<sub>2</sub>、CH<sub>3</sub>CN、MeOH、Toluene七不同溶剂对反应体系的影响(entries 3~9)，结果表明在H<sub>2</sub>O溶液中此反应不发生，EtOH溶剂条件下反应产率最高。随后对反应时间和温度进行筛选(entries 10~12)，当反应时间延长到5 h时目标产物的产率并没有增加，说明模型反应在2 h时已经完全反应，将温度调为80℃</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Optimization of reaction condition</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Entry</th><th align="center" valign="middle" >Catalyst</th><th align="center" valign="middle" >Solvent</th><th align="center" valign="middle" >Temp(℃)</th><th align="center" valign="middle" >Time(h)</th><th align="center" valign="middle" >Yield<sup>a</sup>(%)</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >No base</td><td align="center" valign="middle" >EtOH</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >NR<sup>b</sup></td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >HBF<sub>4</sub> (20 mol%)</td><td align="center" valign="middle" >EtOH</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >73</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >[Bmim]BF<sub>4 </sub>(20 mol%)</td><td align="center" valign="middle" >EtOH</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >85</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >[Bmim]BF<sub>4</sub> (20 mol%)</td><td align="center" valign="middle" >H<sub>2</sub>O</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >NR<sup>b</sup></td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >[Bmim]BF<sub>4</sub> (20 mol%)</td><td align="center" valign="middle" >CH<sub>3</sub>CO<sub>2</sub>Et</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >45</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >[Bmim]BF<sub>4</sub> (20 mol%)</td><td align="center" valign="middle" >CH<sub>2</sub>Cl<sub>2</sub></td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >35</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >[Bmim]BF<sub>4</sub> (20 mol%)</td><td align="center" valign="middle" >CH<sub>3</sub>CN</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >56</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >[Bmim]BF<sub>4</sub> (20 mol%)</td><td align="center" valign="middle" >MeOH</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >52</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >[Bmim]BF<sub>4</sub> (20 mol%)</td><td align="center" valign="middle" >Toluene</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >32</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >[Bmim]BF<sub>4</sub> (20 mol%)</td><td align="center" valign="middle" >EtOH</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >85</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >[Bmim]BF<sub>4</sub> (20 mol%)</td><td align="center" valign="middle" >EtOH</td><td align="center" valign="middle" >80</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >84</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >[Bmim]BF<sub>4</sub> (20 mol%)</td><td align="center" valign="middle" >EtOH</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >72</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >[Bmim]BF<sub>4</sub> (30 mol%)</td><td align="center" valign="middle" >EtOH</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >85</td></tr></tbody></table></table-wrap><p>表1. 反应条件的优化</p><disp-formula id="hanspub.25198-formula65"><graphic xlink:href="//html.hanspub.org/file/3-2970106x12_hanspub.png"  xlink:type="simple"/></disp-formula><p><sup>a</sup>分离产率，<sup>b</sup>反应不发生。</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Investigation of substrate scop</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Entry</th><th align="center" valign="middle" >Peoduct</th><th align="center" valign="middle" >Ar</th><th align="center" valign="middle" >Mp (℃)</th><th align="center" valign="middle" >Yield<sup>a</sup> (%)</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >4a</td><td align="center" valign="middle" >4-OCH<sub>3</sub>-3-OH-C<sub>6</sub>H<sub>3</sub></td><td align="center" valign="middle" >190-192</td><td align="center" valign="middle" >85</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >4b</td><td align="center" valign="middle" >4-F-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >179-181</td><td align="center" valign="middle" >85</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4c</td><td align="center" valign="middle" >4-Cl-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >229-231</td><td align="center" valign="middle" >86</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >4d</td><td align="center" valign="middle" >4-Br-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >224-226</td><td align="center" valign="middle" >88</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >4e</td><td align="center" valign="middle" >4-OH-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >223-225</td><td align="center" valign="middle" >84</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >4f</td><td align="center" valign="middle" >3-OH-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >205-207</td><td align="center" valign="middle" >83</td></tr></tbody></table></table-wrap><p>表2. 底物普适性研究</p><disp-formula id="hanspub.25198-formula66"><graphic xlink:href="//html.hanspub.org/file/3-2970106x13_hanspub.png"  xlink:type="simple"/></disp-formula><p><sup>a</sup>分离产率。</p><p>和65℃时产物产率均有所下降。最后对催化剂的加载量进行考察(entries13)，当催化剂的量为30 mol%时产物的产率并无增加。因此，此反应的最优反应条件为：EtOH溶剂中，离子液体[Bmim]BF<sub>4</sub> (20 mol%)为催化剂，75℃条件下反应2 h。</p></sec><sec id="s5_2"><title>3.2. 目标产物的普适性研究</title><p>根据上述建立的最优化反应条件(表1，entry 3)，得到了较高产率的目标化合物4a-4f，我们对该反应的底物普适性进行了研究，结果如表2所示。从表中可以看出，芳香醛3a-3f的苯环上无论带有强吸电子基还是弱吸电子基在[Bmim]BF<sub>4</sub>催化作用下都能很好的参与反应，得到83%~88%较高产率的目标化合物。因此，离子液体[Bmim]BF<sub>4</sub>催化合成多取代吡喃并[2,3-c]吡唑类化合物具有很好的底物普适性。</p></sec></sec><sec id="s6"><title>4. 结论</title><p>本论文报道了一种有效简便的方法合成多取代吡喃并[2,3-c]吡唑类化合物，通过离子液体[Bmim]BF<sub>4</sub>催化以1-(4-羧基苯基)-3-异丙基吡唑-5-酮，芳香醛化合物和丙二腈为起始原料经三组分一锅法反应得到目标化合物。该方法具有操作简便、反应时间短和环境友好等特点。</p></sec><sec id="s7"><title>基金项目</title><p>新疆教育部研究生科研创新项目基金(NO.XJGRI2014019)。</p></sec><sec id="s8"><title>文章引用</title><p>梁 杰,热孜亚&#183;伊卜拉伊木,阿依古丽&#183;巴拉提. [Bmim]BF4催化下三组分一锅法合成多取代吡喃并[2,3-c]吡唑类化合物Three Components One-Pot Synthesis of Multi-Pyrane[2,3-c]pyrazoles Catalyzed by [Bmim]BF4[J]. 有机化学研究, 2018, 06(02): 39-44. https://doi.org/10.12677/JOCR.2018.62006</p></sec><sec id="s9"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.25198-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">刘丽华. 多组分反应研究现状[J]. 化工中间体, 2012, 9(2): 1-5.</mixed-citation></ref><ref id="hanspub.25198-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">陈育兰, 严胜骄, 林军. 多组分反应在杂环合成中的应用[J]. 广东化工, 2010, 37(3): 4-6.</mixed-citation></ref><ref id="hanspub.25198-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Boukis, A.C., Llevot, A. and Meier, M.A.R. (2016) High Glass Transition Temperature Re-newable Polymers via Biginelli Multicomponent Polymerization. Macromolecular Rapid Communications, 7, 643-649.  
https://doi.org/10.1002/marc.201500717</mixed-citation></ref><ref id="hanspub.25198-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Fikry, R.M., Ismail, N.A., El-Garby, M., Kamel, E.M. and Deeb, A.D.H. (2015) Synthesis of Some New Heterocyclic Compounds Containing Coumarin Ring and Evaluation of Theirs Pharmacological Effect. Eu-ropean Chemical Bulletin, 4, 240-245.</mixed-citation></ref><ref id="hanspub.25198-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Zaki, M.E.A., Soliman, H.A., Hiekal, O.A. and Rashad, A.E. (2006) Pyrazolopyranopy-rimidines as a Class of Anti-Inflammatory Agents. Zeitschrift für Naturforschung B, 61, 1-5. https://doi.org/10.1515/znc-2006-1-201</mixed-citation></ref><ref id="hanspub.25198-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Hogale, M.B. and Pawar, B.N. (1989) Synthesis and Biological Activity of 1-Aroyl-5-(p-sulfamylphenyl-azo)-3,4- dimethylpyrano[2,3-c]pyrazol-6(1H)-ones. Journal of the Indian Chemical Society, 66, 206-207.</mixed-citation></ref><ref id="hanspub.25198-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Venkatesan, A.M., Agarwal, A., Ushirogochi, H., Ado, M., Tsuyoshi, T., Li, Z., Francisco, G., Lin, Y.I., Petersen, P.J., Yang, Y., Weiss, W.J., Shlaes, D.M. and Mansour, T.S. (2008) 5,5,6-Fused Tricycles Bearing Imidazole and Pyrazole 6-Methylidene Penems as Broad-Spectrum Inhibitors of β-Lactamases. Bioorganic &amp; Medicinal Chemistry, 16, 1890-1902. https://doi.org/10.1016/j.bmc.2007.11.006</mixed-citation></ref><ref id="hanspub.25198-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Wang, J.L., Liu, D., Zhang, Z.J., Shan, S., Han, X., Srinivasula, S.M. and Huang, Z. (2000) Structure-Based Discovery of an Organic Compound That Binds Bcl-2 Protein and Induces Apoptosis of Tumor Cells. Proceedings of the National Academy of Sciences of the United States of America, 97, 7124-7129. https://doi.org/10.1073/pnas.97.13.7124</mixed-citation></ref></ref-list></back></article>